Kinnevik AB
IV62
Company Profile
Business description
Kinnevik AB is an operationally oriented investment group with an entrepreneurial focus on building digital brands. It is into providing patient capital to challenger technology-enabled businesses in Europe and the U.S. A key component of its plan is to create consumer choice of solutions in markets where supply may have been previously constrained. The firm has invested in Climate Tech, Health & Bio, Software, Mature companies, and Other Small companies.
Contact
Skeppsbron 18
P.O. Box 2094
StockholmSE-103 13
SWET: +46 856200000
Sector
Financial Services
Stock type
Cyclical
Industry
Asset Management
Fiscal Year End
31 December 2026
Employees
45
Stocks News & Analysis
stocks
ASX biotech expands diagnostics portfolio after FDA approval
FDA nod adds another growth driver for ASX share.
stocks
Is it time to bail on Australian stocks?
Is your home bias costing your portfolio better returns?
stocks
ASX share undervalued despite margin woes
Short term margin pressure yet shares remain undervalued on improved outlook.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,866.70 | 17.40 | 0.20% |
| CAC 40 | 8,090.28 | 27.50 | -0.34% |
| DAX 40 | 25,402.28 | 38.53 | -0.15% |
| Dow JONES (US) | 52,093.11 | 328.09 | -0.63% |
| FTSE 100 | 10,658.13 | 39.44 | -0.37% |
| HKSE | 24,625.82 | 41.42 | -0.17% |
| NASDAQ | 25,981.57 | 204.84 | -0.78% |
| Nikkei 225 | 63,396.00 | 88.10 | -0.14% |
| NZX 50 Index | 13,601.83 | 117.61 | 0.87% |
| S&P 500 | 7,585.73 | 34.25 | -0.45% |
| S&P/ASX 200 | 8,690.70 | 18.20 | 0.21% |
| SSE Composite Index | 3,874.01 | 9.73 | 0.25% |